Dry Age-Related Macular Degeneration Market Size: Key Market Segments and Opportunities

Written by

The Dry Age-Related Macular Degeneration Market Size was valued at USD 11.12 billion in 2022 and is expected to reach USD 20.92 billion by 2030 and grow at a CAGR of  8.22% over the forecast period 2023-2030.

The dry age-related macular degeneration (AMD) market is a rapidly growing sector in the healthcare industry. AMD is a chronic eye disease that affects the central part of the retina, leading to progressive vision loss and impairment. As the global population continues to age, the prevalence of AMD is expected to rise significantly, driving the demand for effective treatments and therapies.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2627

Currently, there are limited treatment options available for dry AMD, which has created a significant unmet need in the market. However, advancements in medical research and technology have paved the way for innovative approaches to tackle this debilitating condition.

One promising area of development is gene therapy. Researchers are exploring gene-based interventions that aim to target specific genetic mutations associated with dry AMD. By correcting these mutations or introducing therapeutic genes, it may be possible to slow down or even halt disease progression.

Another avenue being explored is regenerative medicine. Stem cell therapy holds immense potential in regenerating damaged retinal cells and restoring vision in patients with dry AMD. Clinical trials are These clinical trials aim to determine the safety and effectiveness of stem cell therapy as a viable treatment option for dry AMD.

KEY MARKET SEGMENTS

By Stages

  • Early AMD
  • Intermediate AMD
  • Late AMD

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Academic Research Institutes
  • Others

By Age Group

  • Above 40 Years
  • Above 60 Years
  • Above 75 Years

By Diagnosis & Treatment

  • Treatment
  • Diagnosis

By Route of Administration

  • Oral
  • Injectables

Major Players Listed in the Report are as Follows:

Santen Pharmaceuticals Inc., Ocumension Therapeutics Co. Ltd, Iveric Bio, Eyestem Research Pvt Ltd, Allergan plc, Bausch Health, Belite Bio Inc., Kubota Vision Inc., Alimera Science Inc., Phio Pharmaceuticals Corp,Yuyang DNU Co., Ltd, Stealth Biotherapeutics Inc. and other players

Other Report

Cardiac Implants Market Growth

Autoimmune Disease Market Growth

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Article Categories:
News

Leave a Reply

Your email address will not be published. Required fields are marked *